• Pacific Institute for Research and Evaluation

Chapel Hill

  • Home
  • About
  • Staff
  • Projects
  • Publications
  • Resources

Paramedic-Administered Buprenorphine as a Bridge to Medication-Assisted Treatment

June 24, 2020

Share this...
Share on facebook
Facebook
Share on linkedin
Linkedin
Share on twitter
Twitter

Principal Investigator: Martha W. Waller, Ph.D.

This NIDA funded R21 study evaluates a cutting edge and innovative preventive intervention intended to meet survivors of opioid overdoses attended by EMS, where they are by providing an initial dose of buprenorphine for withdrawal relief and ongoing support for medication assisted treatment (MAT) initiation. We examine the extent to which opioid overdose survivors consent to accept paramedic-prescribed buprenorphine administered immediately following reversal and examine whether the presence of a community-based peer navigator at the scene of an overdose reversal, in addition to a paramedic, increases the survivor’s acceptance of buprenorphine. The peer navigator’s role will be to provide support, encouragement, and education concerning the benefits of buprenorphine as a bridge to MAT. Our study will clarify whether a buprenorphine regimen as a bridge to MAT can successfully be introduced immediately following a reversal, or whether the invitation should be delayed, as some believe, until a later time.

Project record

· Spotlight Project

Contact Us

Contact

Center Director
Martha Waller
mwaller@pire.org

101 Conner Drive, Suite 200
Chapel Hill, NC 27514-7038

Tel: (919) 265-2600
Fax: (919) 265-2659

Copyright © 2023 • PIRE Chapel Hill • Log in

PIRE Chapel Hill is a center of Pacific Institute for Research and Evaluation. Visit the main PIRE website at: https://www.pire.org